The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease
Open accessAbstract
Gaucher disease (GD) is an autosomal recessive disorder caused by mutations in the acid β-glucocerebrosidase gene. To model GD, we generated human induced pluripotent stem cells (hiPSC), by reprogramming skin fibroblasts from patients with type 1 (N370S/N370S), type 2 (L444P/Rec NciI ), and type 3 (L444P/L444P) GD. Pluripotency was demonstrated by the ability of GD hiPSC to differentiate to all three germ layers and to form teratomas in vivo. GD hiPSC differentiated efficiently to the cell types most affected in GD, i.e., macrophages and neuronal cells. GD hiPSC-macrophages expressed macrophage-specific markers, were phagocytic, and were capable of releasing inflammatory mediators in response to LPS. Moreover, GD hiPSC-macrophages recapitulated the phenotypic hallmarks of the disease. They exhibited low glucocerebrosidase (GC) enzymatic activity and accumulated sphingolipids, and their lysosomal functions were severely compromised. GD hiPSC-macrophages had a defect in their ability to clear phagocytosed RBC, a phenotype of tissue-infiltrating GD macrophages. The kinetics of RBC clearance by types 1, 2, and 3 GD hiPSC-macrophages correlated with the severity of the mutations. Incubation with recombinant GC completely reversed the delay in RBC clearance from all three types of GD hiPSC-macrophages, indicating that their functional defects were indeed caused by GC deficiency. However, treatment of induced macrophages with the chaperone isofagomine restored phagocytosed RBC clearance only partially, regardless of genotype. These findings are consistent with the known clinical efficacies of recombinant GC and isofagomine. We conclude that cell types derived from GD hiPSC can effectively recapitulate pathologic hallmarks of the disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vitro study using an iPSCs derived macrophage revealed that GBA deficiency increased proinflammatory cytokine expression.262,263”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [262]
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196 · cited 2×
“The assay for GC enzymatic activity in cells was carried out as described (8).”
BackgroundMethodDimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W. K., Croft, G. F., Saphier, G., Leibel, R. L., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 2,019
Mazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell · doi:10.1016/j.cell.2011.06.001 · Cited by 1,341
Self-citationProbing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253
The promise of induced pluripotent stem cells in research and therapy
Robinton, D. A., & Daley, G. Q. (2012) · Nature · doi:10.1038/nature10761 · Cited by 1,150
Modelling the long QT syndrome with induced pluripotent stem cells
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., et al. (2011) · Nature · doi:10.1038/nature09747 · Cited by 1,049
Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
Hruska, K. S., LaMarca, M. E., Scott, C. R., & Sidransky, E. (2008) · Human Mutation · doi:10.1002/humu.20676 · Cited by 688
Self-citationA block of autophagy in lysosomal storage disorders
Settembre, C., Fraldi, A., Jahreiss, L., Spampanato, C., Venturi, C. B., Medina, D. L., de Pablo, R., Tacchetti, C., Rubinsztein, D. C., & Ballabio, A. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm289 · Cited by 509
Gaucher disease: complexity in a “simple” disorder
Sidransky, E. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.08.015 · Cited by 399
Self-citationTelomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients
Agarwal, S., Loh, Y., McLoughlin, E. M., Huang, J., Park, I., Miller, J. D., Huo, H., Okuka, M., dos Reis, R. M., Loewer, S., et al. (2010) · Nature · doi:10.1038/nature08792 · Cited by 334
Lahti, A., Kujala, V. J., Chapman, H., Koivisto, A., Pekkanen-Mattila, M., Kerkelä, E., Hyttinen, J., KONTULA, K. K., Swan, H., Conklin, B. R., et al. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.008409 · Cited by 300
Gaucher disease: pathological mechanisms and modern management
Jmoudiak, M., & Futerman, A. H. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05351.x · Cited by 290
Enzyme Replacement for Lysosomal Diseases
Brady, R. O. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.57.110104.115650 · Cited by 254
Desforges, J. F., & Beutler, E. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111073251906 · Cited by 252
Steet, R., Chung, S., Wustman, B. A., Powe, A. C., Do, H., & Kornfeld, S. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605928103 · Cited by 219
The Spectrum of Parkinsonian Manifestations Associated With Glucocerebrosidase Mutations
Göker-Alpan, Ö., Lopez, G. J., Vithayathil, J., Davis, J., Hallett, M., & Sidransky, E. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1353 · Cited by 197
Self-citationOrviský, E., Park, J. K., LaMarca, M. E., Ginns, E. I., Martin, B. M., Tayebi, N., & Sidransky, E. (2002) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(02)00117-8 · Cited by 194
Self-citationKhanna, R., Benjamin, E. R., Pellegrino, L. J., Schilling, A., Rigat, B., Soska, R., Nafar, H., Ranes, B., Feng, J., Yi, L., et al. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07588.x · Cited by 155
Zheng, W., Padia, J. K., Urban, D. J., Jadhav, A., Göker-Alpan, Ö., Simeonov, A. M., Goldin, E., Auld, D. S., LaMarca, M. E., Inglese, J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705637104 · Cited by 138
Self-citationDivergent phenotypes in Gaucher disease implicate the role of modifiers
Göker-Alpan, Ö., Hruska, K. S., Orvisky, E., Kishnani, P. S., Stubblefield, B. K., Schiffmann, R., & Sidransky, E. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.028019 · Cited by 124
Self-citationSun, Y., Liou, B., Xu, Y., Quinn, B., Zhang, W., Hamler, R. L., Setchell, K. D. R., & Grabowski, G. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.280016 · Cited by 107
Pharmacologic chaperoning as a strategy to treat Gaucher disease
Yu, Z., Sawkar, A. R., & Kelly, J. W. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06042.x · Cited by 105
Isofagomine Induced Stabilization of Glucocerebrosidase
Kornhaber, G. J., Tropak, M. B., Maegawa, G. H. B., Tuske, S. J., Coales, S. J., Mahuran, D. J., & Hamuro, Y. (2008) · ChemBioChem · doi:10.1002/cbic.200800249 · Cited by 91
Messner, M. C., & Cabot, M. C. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6741-1_11 · Cited by 75
Polumuri, S. K., Toshchakov, V. Y., & Vogel, S. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.236 · Cited by 68
Self-citationTherapeutic approaches to bone pathology in Gaucher disease: past, present and future.
Goker-Alpan, O. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.08.004 · Cited by 65
Lee, R. E., Balcerzak, S. P., & Westerman, M. P. (1967) · The American Journal of Medicine · doi:10.1016/0002-9343(67)90070-8 · Cited by 61
Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase
Shen, J.-S., Edwards, N. J., Hong, Y. B., & Murray, G. J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.125 · Cited by 59
Impaired autophagosomes and lysosomes in neuronopathic Gaucher disease
Sun, Y., & Grabowski, G. A. (2010) · Autophagy · doi:10.4161/auto.6.5.12047 · Cited by 54
A histochemical and electron microscopic study of Gaucher cells.
Rg, H., Vj, F., Cipriano, P. R., & Kj, T. (1970) · PubMed · Cited by 40
Modelling familial dysautonomia in human induced pluripotent stem cells
Lee, G., & Studer, L. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0026 · Cited by 38
Gaucher disease with foamy transformed macrophages and erythrophagocytic activity
Machaczka, M., Klimkowska, M., Regenthal, S., & Hägglund, H. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9241-0 · Cited by 32
Naito, M., Takahashi, K., & Hojo, H. (1988) · PubMed · Cited by 26
Erythrophagocytosis in Gaucher Cells
Bitton, A., Etzell, J. E., Grenert, J. P., & Wang, E. (2004) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2004-128-1191-eigc · Cited by 25
Cited by
Sorted by citations
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
“In vitro study using an iPSCs derived macrophage revealed that GBA deficiency increased proinflammatory cytokine expression.(262,263) In line with this, PD patients with GBA mutation have increased plasma levels of chemokines, including CCL2, CXCL8, and CCL3.”
BackgroundInflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
Platt, F. M., d’Azzo, A., Davidson, B. L., Neufeld, E. F., & Tifft, C. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0025-4 · Cited by 1,052
Neufeld, E. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.001353 · Cited by 924
Schöndorf, D. C., Aureli, M., McAllister, F. E., Hindley, C. J., Mayer, F., Schmid, B., Sardi, S. P., Valsecchi, M., Hoffmann, S. A., Schwarz, L. K., et al. (2014) · Nature Communications · doi:10.1038/ncomms5028 · Cited by 554
Metadata
- Authors
- Panicker, L. M., Miller, D., Park, T. S., Patel, B., Azevedo, J. L., Awad, O., Masood, M. A., Veenstra, T. D., Goldin, E., Stubblefield, B. K., Tayebi, N., Polumuri, S. K., Vogel, S. N., Sidransky, E., Zambidis, E. T., & Feldman, R. A.
- Affiliations
- University of Maryland, Baltimore (US)
- Johns Hopkins University (US)
- Frederick National Laboratory for Cancer Research (US)
- National Institutes of Health (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-10-15
- Volume
- 109
- Issue
- 44
- Pages
- 18054-18059
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3497826
- OpenAlex
- W2081102375
- Cited by
- 129
- References
- 38
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 5 · 2023: 7 · 2022: 16 · 2021: 7 · 2020: 11 · 2019: 6 · 2018: 6 · 2017: 10 · 2016: 9 · 2015: 15 · 2014: 17 · 2013: 6 · 2012: 1
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- March of Dimes Foundation (Grant 6-FY10-334, 6-FY10-334)
- Maryland Stem Cell Research Fund (2009-MSCRFII-0082-00, 2007-MSCRFE-0110-00, 2011-MSCRF-II-0008-00, 2007-MSCRF II-0379-00)
- National Institutes of Health
- National Heart, Lung, and Blood Institute (U01HL100397, R03HL096220, U01HL099775)
- National Institute of Allergy and Infectious Diseases (R01AI018797)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- Gaucher disease, induced pluripotent stem cells, macrophages, erythrocyte clearance, sphingolipid accumulation, lysosomal dysfunction, isofagomine, recombinant enzyme therapy, disease modeling, macrophage differentiation
- MeSH terms
- Cell Differentiation, Gaucher Disease, Humans, Macrophage Activation, Models, Biological, Cell Lineage, Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
